Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Castro Cabezas

Showing results (71-80 of 76) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 76 results.
Atherosclerosis|December 9, 2004
Effects of increasing doses of simvastatin on fasting lipoprotein subfractions, and the effect of high-dose simvastatin on postprandial chylomicron remnant clearance in normotriglyceridemic patients with premature coronary sclerosisJ P H van Wijk, R Buirma, A van Tol, et al.
Clinical Rheumatology|February 17, 2025
Metabolic dysfunction-associated steatotic liver disease and cardiovascular risk factors in rheumatoid arthritisA N Saidi, W B Theel, B Burggraaf, et al.
Atherosclerosis. Supplements|April 30, 2010
Cell-mediated lipoprotein transport: a novel anti-atherogenic conceptS A Bovenberg, A Alipour, J W F Elte, et al.
European Journal of Clinical Investigation|March 16, 2002
A proposal to redefine familial combined hyperlipidaemia -- third workshop on FCHL held in Barcelona from 3 to 5 May 2001, during the scientific sessions of the European Society for Clinical InvestigationA D Sniderman, M Castro Cabezas, J Ribalta, et al.
Atherosclerosis|August 16, 2005
Effects of rosuvastatin on postprandial leukocytes in mildly hyperlipidemic patients with premature coronary sclerosisA J H H M van Oostrom, H W M Plokker, B S van Asbeck, et al.
Journal of Internal Medicine|February 16, 2006
Apo B versus cholesterol in estimating cardiovascular risk and in guiding therapy: report of the thirty-person/ten-country panelP J Barter, C M Ballantyne, R Carmena, et al.
Pageof 8

Showing results (71-80 of 76) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 76 results.
Atherosclerosis|December 9, 2004
Effects of increasing doses of simvastatin on fasting lipoprotein subfractions, and the effect of high-dose simvastatin on postprandial chylomicron remnant clearance in normotriglyceridemic patients with premature coronary sclerosisJ P H van Wijk, R Buirma, A van Tol, et al.
Clinical Rheumatology|February 17, 2025
Metabolic dysfunction-associated steatotic liver disease and cardiovascular risk factors in rheumatoid arthritisA N Saidi, W B Theel, B Burggraaf, et al.
Atherosclerosis. Supplements|April 30, 2010
Cell-mediated lipoprotein transport: a novel anti-atherogenic conceptS A Bovenberg, A Alipour, J W F Elte, et al.
European Journal of Clinical Investigation|March 16, 2002
A proposal to redefine familial combined hyperlipidaemia -- third workshop on FCHL held in Barcelona from 3 to 5 May 2001, during the scientific sessions of the European Society for Clinical InvestigationA D Sniderman, M Castro Cabezas, J Ribalta, et al.
Atherosclerosis|August 16, 2005
Effects of rosuvastatin on postprandial leukocytes in mildly hyperlipidemic patients with premature coronary sclerosisA J H H M van Oostrom, H W M Plokker, B S van Asbeck, et al.
Journal of Internal Medicine|February 16, 2006
Apo B versus cholesterol in estimating cardiovascular risk and in guiding therapy: report of the thirty-person/ten-country panelP J Barter, C M Ballantyne, R Carmena, et al.
Pageof 8